Cytosorbents (CTSO) News Today $1.15 0.00 (0.00%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.14 0.00 (-0.43%) As of 02/21/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO)StockNews.com began coverage on Cytosorbents in a research note on Saturday. They issued a "hold" rating for the company.February 22 at 2:41 AM | marketbeat.comCytosorbents Co. (NASDAQ:CTSO) Sees Significant Growth in Short InterestFebruary 19 at 1:53 AM | americanbankingnews.comCytosorbents Co. (NASDAQ:CTSO) Short Interest UpdateCytosorbents Co. (NASDAQ:CTSO - Get Free Report) saw a significant increase in short interest in January. As of January 31st, there was short interest totalling 1,930,000 shares, an increase of 5.5% from the January 15th total of 1,830,000 shares. Based on an average daily trading volume, of 257,900 shares, the days-to-cover ratio is presently 7.5 days.February 18, 2025 | marketbeat.comCTSO stock touches 52-week high at $1.6 amid robust annual growthFebruary 14, 2025 | msn.comCytosorbents (NASDAQ:CTSO) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?Cytosorbents (NASDAQ:CTSO) Stock Crosses Above 200-Day Moving Average - Here's What HappenedFebruary 14, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.comStockNews.com began coverage on shares of Cytosorbents in a research note on Friday. They issued a "hold" rating on the stock.February 14, 2025 | marketbeat.comSargent Investment Group LLC Decreases Stake in Cytosorbents Co. (NASDAQ:CTSO)Sargent Investment Group LLC trimmed its position in Cytosorbents Co. (NASDAQ:CTSO - Free Report) by 23.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,248,863 shares of the medicalFebruary 5, 2025 | marketbeat.comCytosorbents Co. (NASDAQ:CTSO) Sees Significant Increase in Short InterestCytosorbents Co. (NASDAQ:CTSO - Get Free Report) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 1,830,000 shares, an increase of 26.2% from the December 31st total of 1,450,000 shares. Based on an average daily trading volume, of 262,700 shares, the short-interest ratio is currently 7.0 days.February 1, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Stock Crosses Above Two Hundred Day Moving Average - Here's What HappenedCytosorbents (NASDAQ:CTSO) Stock Price Crosses Above 200-Day Moving Average - What's Next?January 29, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.comStockNews.com assumed coverage on shares of Cytosorbents in a report on Wednesday. They set a "hold" rating for the company.January 29, 2025 | marketbeat.comCytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights OfferingJanuary 13, 2025 | markets.businessinsider.comExpert Outlook: CytoSorbents Through The Eyes Of 7 AnalystsJanuary 13, 2025 | benzinga.comCytoSorbents closes oversubscribed rights offeringJanuary 13, 2025 | msn.comCytosorbents' (CTSO) "Buy" Rating Reaffirmed at D. Boral CapitalD. Boral Capital reissued a "buy" rating and issued a $10.00 price objective on shares of Cytosorbents in a research note on Monday.January 13, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Now Covered by StockNews.comStockNews.com initiated coverage on shares of Cytosorbents in a research note on Monday. They issued a "hold" rating for the company.January 13, 2025 | marketbeat.comCytoSorbents opens regional sales subsidiary in DubaiJanuary 6, 2025 | markets.businessinsider.comCytoSorbents sees Q4 product revenue $9M-$9.2M vs. $7.35M last yearJanuary 5, 2025 | markets.businessinsider.comCytoSorbents reported strong Q4 results, says D. Boral CapitalJanuary 4, 2025 | finance.yahoo.comCTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.January 3, 2025 | msn.comCytoSorbents Sees Higher Product Revenue, Weak Margin In Q4; Stock DownJanuary 3, 2025 | markets.businessinsider.comCytoSorbents sees Q4 product revenue growth of 22%-25% Y/YJanuary 3, 2025 | msn.comCytosorbents' (CTSO) Buy Rating Reiterated at D. Boral CapitalD. Boral Capital restated a "buy" rating and set a $10.00 target price on shares of Cytosorbents in a report on Friday.January 3, 2025 | marketbeat.comCytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product RevenueJanuary 3, 2025 | globenewswire.comCytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.comStockNews.com began coverage on shares of Cytosorbents in a research note on Saturday. They set a "hold" rating on the stock.December 28, 2024 | marketbeat.comCytoSorbents commences Rights OfferingDecember 24, 2024 | markets.businessinsider.comCytosorbents Co. (NASDAQ:CTSO) CFO Peter J. Mariani Purchases 20,000 SharesDecember 17, 2024 | insidertrades.comCytosorbents Co. (NASDAQ:CTSO) CFO Peter J. Mariani Acquires 20,000 SharesCytosorbents Co. (NASDAQ:CTSO - Get Free Report) CFO Peter J. Mariani acquired 20,000 shares of the firm's stock in a transaction on Friday, December 13th. The stock was purchased at an average price of $0.96 per share, for a total transaction of $19,200.00. Following the completion of the transaction, the chief financial officer now directly owns 401,363 shares in the company, valued at approximately $385,308.48. The trade was a 5.24 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.December 16, 2024 | marketbeat.comInsider Buying: Cytosorbents Co. (NASDAQ:CTSO) CFO Buys 11,363 Shares of StockDecember 14, 2024 | insidertrades.comCTSO: CytoSorbents Announces Rights Offering Which has the Potential to Substantially Increase Available LiquidityDecember 12, 2024 | msn.comCytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference WeekDecember 12, 2024 | globenewswire.comCytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare ConferenceNovember 26, 2024 | finance.yahoo.comCytosorbents FY2024 EPS Forecast Reduced by HC WainwrightCytosorbents Co. (NASDAQ:CTSO - Free Report) - Stock analysts at HC Wainwright decreased their FY2024 earnings per share estimates for shares of Cytosorbents in a research note issued to investors on Monday, November 11th. HC Wainwright analyst S. Lee now expects that the medical research companyNovember 14, 2024 | marketbeat.comCytoSorbents, Converge Biotech announce strategic partnershipNovember 12, 2024 | markets.businessinsider.comCytoSorbents Hops on Alliance with ConvergeNovember 11, 2024 | baystreet.caBalanced Hold Rating Amid Revenue Miss and Strategic Initiatives at CytoSorbentsNovember 11, 2024 | markets.businessinsider.comCytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in IndiaNovember 11, 2024 | globenewswire.comCytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.comStockNews.com started coverage on shares of Cytosorbents in a research note on Sunday. They issued a "hold" rating on the stock.November 10, 2024 | marketbeat.comCytosorbents Corporation (CTSO) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comCytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ...November 9, 2024 | finance.yahoo.comCytoSorbents Corporation’s Q3 2024 Financial HighlightsNovember 8, 2024 | markets.businessinsider.comCytoSorbents Reports Third Quarter 2024 Financial and Operational ResultsNovember 7, 2024 | markets.businessinsider.comCytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ahead of EarningsNovember 6, 2024 | finance.yahoo.comCytoSorbents submits Health Canada MDL application for DrugSorb ATRNovember 5, 2024 | markets.businessinsider.comCytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP CertificationNovember 5, 2024 | theglobeandmail.comCytosorbents (CTSO) Scheduled to Post Earnings on ThursdayCytosorbents (NASDAQ:CTSO) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=636646)October 31, 2024 | marketbeat.comFDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive ReviewOctober 22, 2024 | markets.businessinsider.comCytoSorbents announces FDA has accepted De Novo medical device applicationOctober 22, 2024 | markets.businessinsider.comCytoSorbents to Report Third Quarter 2024 Operating and Financial ResultsOctober 18, 2024 | markets.businessinsider.comCytosorbents (NASDAQ:CTSO) Receives New Coverage from Analysts at StockNews.comStockNews.com assumed coverage on shares of Cytosorbents in a report on Thursday. They set a "hold" rating for the company.October 17, 2024 | marketbeat.comCytosorbents Co. (NASDAQ:CTSO) Sees Significant Decline in Short InterestCytosorbents Co. (NASDAQ:CTSO - Get Free Report) was the recipient of a significant decrease in short interest in the month of September. As of September 30th, there was short interest totalling 1,330,000 shares, a decrease of 5.7% from the September 15th total of 1,410,000 shares. Based on an average daily trading volume, of 91,700 shares, the short-interest ratio is currently 14.5 days.October 16, 2024 | marketbeat.com Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address CTSO Media Mentions By Week CTSO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTSO News Sentiment▼1.010.60▲Average Medical News Sentiment CTSO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTSO Articles This Week▼31▲CTSO Articles Average Week Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RCEL News Today LUNG News Today ELMD News Today INGN News Today ZYXI News Today LAKE News Today DRTS News Today OBIO News Today NVRO News Today BWAY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTSO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytosorbents With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTSO Stock Alerts